Company profile
Alphyn Biologics company profile
Alphyn Biologics develops and advances therapeutic drug candidates focused on treating skin diseases using its proprietary multi-target Zabalafin Platform, aiming to address key biological drivers of conditions such as atopic dermatitis. Its lead candidate, Zabalafin Hydrogel, is a topical formulation in clinical trials that is designed to interact with immune-mediated inflammation, itch, and bacterial components of the disease simultaneously as part of a singular treatment approach. The company supports its pipeline of dermatologic therapeutics with multiple bioactive compounds intended to engage several mechanisms of action within skin disease pathology. Alphyn maintains an intellectual property portfolio that spans its platform and..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- https://alphynbiologics.com
- Phone number
- +(443) 994-0101
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $1K+
- Founded
- 2019-01-01
Headquarters
- Headquarters
- Cincinnati, Ohio, United States
- Country code
- US
- Continent
- North America